REFERENCES
- Cruz, J.R. (2005). Availability, safety and quality of blood for transfusion in the Americas. World Hosp. Health Serv. 41(1): 25, 27–31.
- Cruz, J.R. (2005). Seeking a safer blood supply. Lancet 23–29; 365(9469): 1463–1464.
- Gulati, A. (1997). Recent advances in the development of haemoglobin-based blood substitutes. Expert Opin. Investig. Drugs 6(11):1659–1669.
- Feola, M., Simoni, J., Canizarro, P.C. (1988). Toxicity of polymerized hemoglobin solutions. Surgery Gynecology & Obstetrics 166: 211–222.
- Shoemaker, S.A., Gerber, M.J. (1994). Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Art. Cells Blood Subs., & Immobil. Biotech. 22(3): 457–465.
- Gulati, A., Barve, A., Sen, A.P. (1998). Pharmacology of hemoglobin therapeutics. J. Lab. Clin. Med. 133(2): 112–119.
- Conover, C.D., Linberg, R., Shun, K.L., Shorr, R.G. (1999). The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-bHb) to adequately deliver oxygen in both exchange transfusion and top-load rat models. Art. Cells Blood Subs. and Immobil. Biotech. 27(2): 93–107.
- Vandegriff, K.D., McCarthy, M., Rohlfs, R., Winslow, R.M. (1997). Colloid osmotic properties of modified hemoglobins chemically cross-linked versus polyethylene glycol surface-conjugated. Biophs. Chemistry 69: 23–30.
- Hiromi, S., Hiroyukihapa, Minako, Yuasa. (2000). Molecular dimensions of Hb-based O2 carriers determine constriction of resistance arteries and hypertension. Am. J. Physiol. Heart Circ. Physiol. 279: 908–915.
- Kunitani, M., Dollinger, G., Johnson, D., Kresin, L. (1991). On-line characterization of polyethylene glycol-modified proteins. J. Chromatogr. 588: 125–137.
- Xianzhong, Li, Xiaowei, Zhang, Qian, Liu. (2005). Determination of the molecular weight distribution of the PEGylated bovine hemoglobin (PEG-bHb). Artif. Cells Blood Substit. Immobil. Biotechnol. 33(1): 13–25.
- Snider, J., Neville, C., Yuan, L.C. (1992). Characterization of the heterogeneity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques. J. Chromatogr. 22;599(1–2): 141–155.
- Bullock, J., Chowhury, S. (1997). Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 5000-modified bovine cupri-zinc superoxide dismutase. Anal. Biochem. 15;254(2): 254–262.
- Dong, H.N., Kang, C.L. (2004). Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laserdesorption/ionization time-of of-flight mass spectrometry. Analytical Biochemistry 331: 322–328.
- Weijun, Li, Yi, Zhong, Bingcheng, Lin, Zhiguo, Su. (2001). Characterization of polyethylene glycol-modified proteins by semi-aqueous capillary electrophoresis. J. Chromatogr. A. 905: 299–307.
- Everse, J. (1995). Methods of Enzyme 231.
- Todd, L., Talarico, Katherine, J. Guise. (2000). Chemical characterization of pyridoxalated hemoglobin polyoxyethylene conjugate. Biochimica. Biophysica. Acta Biochim. Biophys. Acta 3; 1476(1): 53–65.
- Wylie, D.C., Voloch, M., Lee, S., Liu, Y.H. (2001). Carboxyalkylated histidine is a PH-dependent product of pegylation with SC-PEG. Pharm. Res. 18(9): 1354–1360.